Keller William R
Director at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $3.8M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 4, 2014
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALEXION PHARMACEUTICALS INCDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualMar 2, 2011 2011
Sold 4,848 shares at $97.00 ($470k)
Keller William R, Director
Sold 42% of holdings ($1.1M position)6,690 shares leftFirst sale on recordFiling
- 2 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualFeb 23, 2012 +358 days
Sold 8,515 shares at $84.78 ($722k)
Keller William R, Director
Sold 46.5% of holdings ($1.6M position)9,805 shares leftFiling
- 3 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualMay 20, 2013 +452 days
Sold 9,770 shares at $103.00 ($1M)
Keller William R, Director
Sold 44.3% of holdings ($2.3M position)12,276 shares leftFiling
- 4 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedJun 5, 2014 +381 days
Sold 3,425 shares at $170.00 ($582k)
Keller William R, Director
Sold 21.8% of holdings ($2.7M position)12,276 shares leftFiling
- 5 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualDec 4, 2014 +182 days
Sold 5,000 shares at $196.25 ($981k)
Keller William R, Director
Sold 40.7% of holdings ($2.4M position)7,276 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2014 | Dec 8, 2014 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $981k | 40.7% | Unusual | SEC |
| Jun 5, 2014 | Jun 6, 2014 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 3,425 | $582k | 21.8% | Plan not stated | SEC |
| May 20, 2013 | May 22, 2013 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 9,770 | $1M | 44.3% | Unusual | SEC |
| Feb 23, 2012 | Feb 24, 2012 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 8,515 | $722k | 46.5% | Unusual | SEC |
| Mar 2, 2011 | Mar 4, 2011 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 4,848 | $470k | 42.0% | Unusual | SEC |